Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve eye health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. It also develops NCX 4251, a novel patented ophthalmic suspension of fluticaso...
Industry: Biotechnology
Sector: Healthcare
Phone: 33 4 97 24 53 00
Address:
Sundesk Sophia Antipolis, Emerald Square, Bâtiment C Rue Evariste Galois, Biot, France
